Thalassemia: all 422 studies
Page 5 of 5. Open to participants first (69), then studies with results posted, then the rest; newest registration first within each.
- Genetic Factors Affecting the Severity of Beta ThalassemiaCompletedNCT00159042
- Genetics of Alpha Thalassemia in Israeli Ethnic GroupsCompletedNCT00159029
- Efficacy Study in Removing Excess Iron From the HeartCompletedNCT00105495Phase 4
- Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia MajorStatus unknownNCT00103753Phase 4
- Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-ThalassemiaCompletedNCT00069862Phase 1/2
- Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic AnemiasCompletedNCT00061763Phase 2
- Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood TransfusionsCompletedNCT00061750Phase 3
- Bone Marrow Transplant From Related Donor for Patients With High Risk HemoglobinopathiesTerminatedNCT00040469Phase 2
- Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk HemoglobinopathiesTerminatedNCT00040417Phase 2
- Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or ThalassemiaTerminatedNCT00034528Phase 2
- Cord Blood Transplantation for Sickle Cell Anemia and ThalassemiaCompletedNCT00029380Phase 2
- Diagnostic Pilot Study of Dual Energy Absorptiometry in the Detection of Osteopenia or Osteoporosis in Patients With Thalassemia MajorCompletedNCT00006138
- Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia IntermediaCompletedNCT00006136Phase 2
- 5-Azacytidine and Phenylbutyrate to Treat Severe ThalassemiaCompletedNCT00005934Phase 2
- Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic DisordersCompletedNCT00005893Not applicable
- Combination Iron Chelation TherapyCompletedNCT00004982Phase 1
- Stem Cell Transplantation (SCT) for Genetic DiseasesCompletedNCT00004378Not applicable
- Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)CompletedNCT00001958Phase 2
- Deferoxamine for the Treatment of HemochromatosisCompletedNCT00001203
- Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)CompletedNCT00000623
- Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional HemochromatosisCompletedNCT00000595Phase 2
- Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl HydrazoneCompletedNCT00000588Phase 2